SCHEMBL29453063

SCHEMBL29453063

C[C@@H](Oc1ccsc1C(N)=O)c1ccccc1C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 18/20 0.51
PLK3 Q9H4B4 10/20 0.51
NEK2 P51955 2/20 0.49
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
PIK3CD O00329 1/20 0.46
PIK3C2B O00750 1/20 0.46
RIOK3 O14730 1/20 0.46
DAPK3 O43293 1/20 0.46
PIP5K1C O60331 1/20 0.46
RPS6KA4 O75676 1/20 0.46
STK10 O94804 1/20 0.46
PRKD3 O94806 1/20 0.46
PDGFRB P09619 1/20 0.46
KIT P10721 1/20 0.46
PIM1 P11309 1/20 0.46
CSNK2A2 P19784 1/20 0.46
GRK4 P32298 1/20 0.46
TIE1 P35590 1/20 0.46
FLT3 P36888 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3963311 1.00 PLK1 (0.51) PLK1PLK3NEK2CYP3A4CYP2C9
SCHEMBL29536039 1.00 PLK1 (0.51) PLK1PLK3NEK2CYP3A4CYP2C9
SCHEMBL30427708 0.89 PLK1 (0.44) PLK1PLK3NEK2CYP3A4CYP2C9
SCHEMBL20108162 0.87 KMT2A (0.48) PLK1PLK3NEK2
SCHEMBL4632897 0.76 NEK2 (0.40) PLK1PLK3NEK2CYP3A4CYP2C9
SCHEMBL4777503 0.76 PLK1 (0.49) PLK1PLK3NEK2CYP3A4CYP2C9
SCHEMBL2991160 0.74 PLK1 (0.50) PLK1PLK3NEK2CYP3A4CYP2C9
SCHEMBL29915268 0.72 MAOB (0.57) PLK1PLK3NEK2PDGFRBKIT
SCHEMBL25267168 0.72 PLK1 (0.49) PLK1PLK3NEK2CYP3A4CYP2C9
SCHEMBL2977455 0.72 PLK1 (0.49) PLK1PLK3NEK2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4204020-A1 METHOD OF TREATING PSMA-EXPRESSING CANCERS Advanced Accelerator Applications International S.A. (CH) 2023-07-05 EP disclosed
WO-2022043558-A1 METHOD OF TREATING PSMA-EXPRESSING CANCERS ADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA (CH) 2022-03-03 WO disclosed